Has Robert Dean, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,959 in general payments to Robert Dean, MD across 130 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Dean, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Dean, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Dean, MD

Otolaryngology · Tucson, AZNPI 1255389532

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.9% of the total across 130 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Aerin Medical Inc. at 45.2% of the total.

$3,959in general payments, 2019–2025

Across 130 payments — averaging $30.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aerin Medical Inc.$2K
Stryker$408
GSK$382
Sanofi$339
Medtronic$217
Regeneron Healthcare Solutions, Inc.$200
plus $623 from 13 others

$75,325in research payments, 2019–2025

Across 8 payments — averaging $9415.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Aerin Medical Inc.$68K
Sanofi US Services Inc.$7K
Sanofi$675

What the payments were for

Travel & lodging$3288%
Food & beverage$3,59791%
Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aerin Medical Inc.	46	$1,790
Stryker	8	$408
GSK	21	$382
Sanofi	17	$339
Medtronic(2 entities)	6	$217
Regeneron Healthcare Solutions, Inc.	9	$200
Optinose US, Inc.	4	$187
Amgen	2	$66
Carestream Dental, LLC	2	$62
Kaleo, Inc.	3	$57
Merck	2	$50
Abbott	1	$48
Kls-martin L.p.	2	$37
Davol Inc.	2	$34
Neurent Medical Limited	1	$21
Cochlear Americas	1	$19
Smith+Nephew	1	$17
AstraZeneca	1	$13
Itamar Medical Inc	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VIVAER STYLUS$473
RHINAER STYLUS$145
Xhance$131
NUVENT$108
SPIROX - LATERA$100
ENTELLUS - FIAGON SINUS NAVIGATION SYSTEM$100
ENTELLUS - XPRESS ENT DILATION SYSTEM$100

How this compares

$3,959 in reported general payments places this provider in the 75th percentile of 150 otolaryngology providers in Arizona.

See all otolaryngology providers in Arizona →

Medicare billing

Part B allowed, 2024

$555,624

Medicare patients

711

Services billed

7,474

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Dupixent SyringeDupilumab	26	$111,965
Famotidine	566	$10,526
Fluticasone Propionate	276	$4,744
Ipratropium Bromide	133	$4,418
Azelastine Hcl	112	$2,983
Mometasone Furoate	41	$2,060
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth	18	$1,973
Mupirocin	110	$997
Methylprednisolone	97	$759
Omeprazole	31	$571
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	43	$556
Montelukast Sodium	61	$545
Amitriptyline Hcl	34	$447
Levocetirizine Dihydrochloride	11	$390
Verapamil Hcl	26	$316

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tucson

Eugene ChangTucson$44K
Shethal BearellyTucson$11K
Afshin EmamiTucson$8K
Matthew GroysmanTucson$6K
Adam RayTucson$5K
Christopher leTucson$5K
John ChastainTucson$4K
David HuTucson$4K
Claire GleadhillTucson$3K
Austin LeverTucson$3K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →